ArticleInvestigative ophthalmology & visual science2026
Deep Proteomic Analysis With Machine Learning Identifies Aqueous Humor Biomarkers of ADAMTSL4-associated Congenital Ectopia Lentis.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To systematically characterize aqueous humor (AH) proteomic alterations in ADAMTSL4-associated congenital ectopia lentis (CEL) and to identify disease-related molecular features. Methods: Mass spectrometry-based deep data-independent acquisition (deep DIA) proteomics was employed to profile AH proteomes from pediatric ADAMTSL4-associated CEL patients. Differentially expressed proteins (DEPs) were analyzed using functional enrichment and gene set enrichment analysis. Weighted gene co-expression network analysis (WGCNA) identified disease-related protein modules. Candidate biomarkers were prioritized using machine learning, followed by technical confirmation using intelligent parallel reaction monitoring (iPRM) and clinical correlation analysis. Transcriptional changes of selected candidates were assessed by quantitative PCR in ADAMTSL4-knockdown human retinal pigment epithelial cells, human fibroblasts, and adamtsl4-knockout zebrafish. Results: Deep DIA quantified 1865 AH proteins, among which 265 DEPs were identified and enriched in extracellular matrix (ECM) remodeling, complement-coagulation cascades, and lipid transport pathways. Expression-based stratification revealed tier-specific functional patterns. WGCNA identified modules significantly associated with ocular phenotypes. Machine learning prioritized six candidate biomarkers (ADAMTS3, APOC2, AMBP, KLKB1, SDC4, and ENPP2), of which APOC2, AMBP, KLKB1, and ENPP2 achieved targeted confirmation by iPRM; APOC2, KLKB1, and ENPP2 were correlated with axial length or choroidal thickness. In ADAMTSL4-knockdown cells, ENPP2, MYDGF, and CA2 were downregulated and LCAT was upregulated, consistent with proteomic findings. MYDGF further showed a concordant directional change in the zebrafish model. Conclusions: This study established a high-resolution AH proteomic profile of ADAMTSL4-associated CEL, revealing coordinated molecular alterations in ECM disruption, complement-coagulation activation, and dysregulated lipid homeostasis, providing integrated molecular insights and candidate molecular features for understanding this rare ocular disorder.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.